GB202216202D0 - Antibody and its medical uses - Google Patents

Antibody and its medical uses

Info

Publication number
GB202216202D0
GB202216202D0 GBGB2216202.8A GB202216202A GB202216202D0 GB 202216202 D0 GB202216202 D0 GB 202216202D0 GB 202216202 A GB202216202 A GB 202216202A GB 202216202 D0 GB202216202 D0 GB 202216202D0
Authority
GB
United Kingdom
Prior art keywords
antibody
medical uses
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2216202.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncobiopharm Ltd
Original Assignee
Oncobiopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncobiopharm Ltd filed Critical Oncobiopharm Ltd
Priority to GBGB2216202.8A priority Critical patent/GB202216202D0/en
Publication of GB202216202D0 publication Critical patent/GB202216202D0/en
Ceased legal-status Critical Current

Links

GBGB2216202.8A 2022-11-01 2022-11-01 Antibody and its medical uses Ceased GB202216202D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2216202.8A GB202216202D0 (en) 2022-11-01 2022-11-01 Antibody and its medical uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2216202.8A GB202216202D0 (en) 2022-11-01 2022-11-01 Antibody and its medical uses

Publications (1)

Publication Number Publication Date
GB202216202D0 true GB202216202D0 (en) 2022-12-14

Family

ID=84839495

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2216202.8A Ceased GB202216202D0 (en) 2022-11-01 2022-11-01 Antibody and its medical uses

Country Status (1)

Country Link
GB (1) GB202216202D0 (en)

Similar Documents

Publication Publication Date Title
EP4219554A4 (en) Cd7-targeting humanized antibody and use thereof
EP4151652A4 (en) Anti-cd73 antibody and use thereof
EP4095160A4 (en) Anti-st2 antibody and application thereof
EP4008351A4 (en) Anti-pd-1 antibody and medical use thereof
EP4139347A4 (en) Anti-cd3 antibodies and uses thereof
EP4159763A4 (en) Anti-cd73 antibody and use thereof
EP4095157A4 (en) Anti-angptl3 antibody and use thereof
GB202017058D0 (en) Antibodies and uses thereof
EP4039708A4 (en) Anti-cll1 antibody and application thereof
IL308808A (en) Anti-ccr8 antibodies and uses thereof
IL311070A (en) Anti-psma antibodies and uses thereof
ZA202109744B (en) Anti-connective tissue growth factor antibody and application thereof
EP4132974A4 (en) Anti-cd98 antibodies and uses thereof
EP4234580A4 (en) Nkg2a-targeting antibody and use thereof
IL308198A (en) Anti-il-27 antibodies and uses thereof
IL307940A (en) Anti-adgre2 antibodies and uses thereof
IL275186A (en) Human anti-grp94 antibodies and uses
IL307267A (en) Anti-cd122 antibodies and uses thereof
EP4079758A4 (en) Semg2 antibody and use thereof
EP4169950A4 (en) Anti-lilrb1 antibody and uses thereof
GB202216202D0 (en) Antibody and its medical uses
EP4153313A4 (en) Anti-sars-cov-2 antibodies and uses thereof
SG11202108832XA (en) Anti-ang2 antibody and use thereof
IL310028A (en) Antibody and use thereof
GB202303531D0 (en) Antibodies and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)